DXA in vivo BMD methodology: An erroneous and misleading research and clinical gauge of bone mineral status, bone fragility, and bone remodelling

Bone

Volumn 41, Issue 1, 2007, Pages 138-154

  Bolotin, H H ^a  

^a RMIT UNIVERSITY   (Australia)

Author keywords

Anti resorptive and anabolic PTH therapy efficacy; BMD; Bone remodelling; DXA in vivo BMD inaccuracies; DXA methodology; Osteoporosis

Indexed keywords

ACCURACY; ARTICLE; BONE DENSITY; BONE FRAGILITY; BONE MINERAL; BONE REMODELING; CADAVER; CLINICAL RESEARCH; DIAGNOSTIC ERROR; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR; FRACTURE; HUMAN; LUMBAR VERTEBRA; MEASUREMENT ERROR; METHODOLOGY; RISK ASSESSMENT; SOFT TISSUE; TRABECULAR BONE; VALIDITY;

BIOMECHANICS; BONE AND BONES; BONE DENSITY; BONE REMODELING; CROSS-SECTIONAL STUDIES; DENSITOMETRY, X-RAY; DIAGNOSTIC ERRORS; FEMALE; HUMANS; OSTEOPOROSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34250030054     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2007.02.022     Document Type: Article

References (88)

1. Sorenson J.A. Effects of nonmineral tissues on measurements of bone mineral content by dual-photon absorptiometry. Med. Phys. 7 (1990) 905-912
2. Kuiper J.W., Van Kuijk C., Grashuis J.L., Ederveen A.G.H., and Schutte H.E. Accuracy and influence of marrow fat on quantitative CT and dual-energy X-ray absorptiometry measurements of the femoral neck in vitro. Osteoporos. Int. 6 (1996) 25-30
3. Antonacci M.D., Hanson D.S., and Hegeness M.H. Pitfalls in the measurement of bone mineral density by dual energy X-ray absorptiometry. Spine 21 (1996) 81-91
4. Bolotin H.H. Analytic and quantitative exposition of patient-specific systematic inaccuracies inherent in planar DXA-derived in vivo BMD measurements. Med. Phys. 25 (1998) 139-151
5. Bolotin H.H. A new perspective on the causal influence of soft tissue composition on DXA-measured in vivo bone mineral density. J. Bone Miner. Res. 13 (1998) 1739-1746
6. Faulkner K.G. Bone matters: are density increases necessary to reduce fracture risk?. J. Bone Miner. Res. 15 (2000) 183-187
7. Bolotin H.H., Sievänen H., Grashuis J.L., Kuiper J.W., and Järvinen T.L. Inaccuracies inherent in patient-specific dual-energy X-ray absorptiometry bone mineral density measurements: comprehensive phantom-based evaluation. J. Bone Miner. Res. 16 (2001) 417-426
8. Reid I.R. Relationships among body mass, its components, and bone. Bone 31 (2002) 547-555
9. Bolotin H.H., and Sievänen H. Inaccuracies inherent in dual-energy X-ray absorptiometry in vivo bone mineral density can seriously mislead diagnostic/prognostic interpretation of patient-specific bone fragility. J. Bone Miner. Res. 16 (2001) 799-805
10. Thomas T., and Burguera B. Is leptin the link between fat and bone mass?. J. Bone Miner. Res. 17 (2002) 1563-1569
11. Bolotin H.H., Sievänen H., and Grashuis J.L. Patient-specific DXA bone mineral density inaccuracies: quantitative effects of nonuniform extraosseous fat distributions. J. Bone Miner. Res. 18 (2003) 1020-1027
12. Bolotin H.H. A new perspective on the effects of body weight and body fat mass on DXA-measured in vivo bone mineral density. Osteoporos. Int. 8 (1998) 514
13. Bolotin H.H. Inaccuracies inherent in dual-energy X-ray absorptiometry in vivo bone mineral densitometry may flaw osteopenic/osteoporotic interpretations and mislead assessment of antiresorptive therapy effectiveness. Bone 28 (2001) 548-555
14. Heaney R.P. Is the paradigm shifting?. Bone 33 (2003) 457-465
15. Faulkner K.G., von Stetten E., and Miller P. Discordance in patient classification using T-scores. J. Clin. Densitom. 2 (1999) 343-350
16. Finkelstein J.S., Hayes A., Hunzelman J.L., Wyland J.J., Lee H., and Neer R.M. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N. Engl. J. Med. 349 (2003) 1216-1226
17. Black D.M., Greenspan S.L., Ensrud K.E., Palermo L., McGowan J.A., Lang T.F.G., et al. PaTH Study Investigators. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N. Engl. J. Med. 349 (2003) 1207-1215
18. Khosla S. Parathyroid hormone plus alendronate-A combination that does not add up. N. Engl. J. Med. 349 (2003) 1277-1279
19. Ettinger B., San Martin J., Crans G.G., and Pavo I. Response of markers of bone turnover and bone density to teriparatide. J. Bone Miner. Res. 18 Suppl. 2 (2003) S15
20. Roux C., Arabi A., Porcher R., and Ganero P. Serum leptin as a determinant of bone resorption in healthy postmenopausal women. Bone (2003) 847-852
21. Kontogianni M.D., Dafni U.G., Routsias J.G., and Skopouli F.N. Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. J. Bone Miner. Res. 19 (2004) 546-551
22. Bolotin H.H. The significant effects of bone structure on inherent patient-specific DXA in vivo bone mineral density measurement inaccuracies. Med. Phys. 31 (2004) 774-788
23. Wahner H.W., Dunn W.L., Mazess R.B., et al. Dual-photon GD-153 absorptiometry of bone. Radiology 156 (1985) 203-206
24. Eriksson S., Is berg B., and Lindgren U. Vertebral bone mineral measurement using dual photon absorptiometry and computed tomography. Acta Radiological 29 (1988) 89-94
25. Godtfredsen A., Podenphant J., Norgaard H., et al. Accuracy of lumbar spine bone mineral content by dual photon absorptiometry. J. Nucl. Med. 29 (1988) 248-254
26. Ho C.P., Kim R.W., Schaffler M.B., and Sartoris D.J. Accuracy of dual-energy radiographic absorptiometry of the lumbar spine: a cadaver study. Radiology 176 (1990) 171-173
27. Edmonston S.J., Singer K.P., Price R.I., and Breidahl P.D. Accuracy of lateral dual energy X-ray absorptiometry for the determination of bone mineral content in the thoracic and lumbar spine: an in-vitro study. Br. J. Radiol. 66 (1993) 309-313
28. Sabin M.A., Blake G.M., MacLaughlin-Black S.M., and Fogelman I. The accuracy of volumetric bone density measurements in dual X-ray absorptiometry. Calcif. Tissue Int. 56 (1995) 210-214
29. Svendsen O.L., Hassager C., Skodt V., and Christiansen C. Impact of soft tissue on in vivo accuracy of bone mineral measurements in the spine, hip, and forearm: a human cadaver study. J. Bone Miner. Res. 10 (1995) 868-873
30. Bjarnason K., Hassager C., Svendsen O.L., Stang H., and Christiansen C. Anteroposterior and lateral spinal DXA for the assessment of vertebral body strength: comparison with hip and forearm measurement. Osteoporos. Int. 6 (1996) 37-42
31. Mazess R.B. Errors in measuring trabecular bone by computed tomography due to marrow and bone composition. Calcif. Tissue Int. 35 (1983) 148-152
32. Technical principles of X-ray absorptiometry. In: Blake G.M., Wahner H.W., and Fogelman I. (Eds). The evaluation of osteoporosis: dual energy X-ray absorptiometry and ultrasound in clinical practice. 2nd ed. (1999), Martin Dunitz Ltd, London 203-232 [Chap. 10]
33. Blake G.M., and Fogelman I. Interpretations of bone density studies. Semin. Nucl. Med. 27 (1997) 1535-1541
34. Ley C.J., Lees B., and Stevenson J.C. Sex- and menopause-associated changes in body-fat distribution. Am. J. Clin. Nutr. 55 (1992) 950-954
35. In: Wheater P.R., Burkitt H.G., and Daniels V.G. (Eds). Functional Histology (1979), Churchill Livingstone, Edinburgh 136
36. Ravn P., Cizza G., Bjarnason H., Thompson F., Daley M., Wasnich R.D., et al. Christiansen C for the Early Postmenopausal Intervention Cohort (EPIC) Study Group. Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. J. Bone Miner. Res. 14 (1999) 1622-1627
37. Minaire P., Meunier P., Edouard C., Bernard J., Courpron P., and Bourret J. Quantitative histological data on disuse osteoporosis. Calcif. Tissue Res. 17 (1974) 57-73
38. Minaire P., Edouard C., Arlot M., and Meunier P.J. Marrow changes in paraplegic patients. Calcif. Tissue Int. 36 (1984) 338-340
39. Glowacki J. Influence of age on human marrow. Calcif. Tissue Int. 35 Suppl. 1 (1995) S50-S51
40. Schnitzler C.M., and Mesquita J. Bone marrow composition and bone microarchitecture and turnover in blacks and whites. J. Bone Miner. Res. 13 (1998) 1300-1307
41. Jilka R.L., Weinstein R.S., Bellido T., Roberson P., Parfitt A.M., and Manolagas S.C. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J. Clin. Invest. 104 (1999) 439-446
42. Hartsock R.J., Smith E.B., and Petty C.S. Normal variations with aging of the amount of hematopoietic tissue in bone marrow from the anterior iliac crest. Am. J. Clin. Path. 43 (1965) 326-331
43. Meunier P., Aaron J., Edouard C., and Vignon G. Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. Clin. Orthop. 80 (1971) 147-154
44. Ricci C., Cova M., Kang Y.S., Yang A., Rahmouni A., Scott Jr. W.W., et al. Normal age- related pattern of cellular and fatty bone marrow distribution in the spinal skeleton: MR imaging study. Radiology 177 (1990) 83-88
45. Khoo K.-H., Dussault R., Kaplan P., Kim R., Ahn I.-O., Christopher J., et al. Age-related marrow conversion in the proximal metaphysis of the femur: evaluation with T1-weighted MR imaging. Radiology 206 (1998) 745-748
46. Griffith J.F., Yeung D.K.W., Antonio G.E., Lee F.K.H., Hong A.W.L., Wong S.Y.S., et al. Vertebral bone mineral density, marrow perfusion, and fat content in healthy men and men with osteoporosis: dynamic contrast-enhanced MR imaging and MR spectroscopy. Radiology 236 (2005) 945-951
47. Shih T.T.-F., Lie H.-C., Chang C.-S., Wei S.-Y., Shen L.-C., and Yang R.-C. Correlation of MR lumbar spine bone marrow perfusion with bone mineral density in female subjects. Radiology 233 (2004) 121-128
48. Ballon D., Jakubowski A., Gabriove J., Graham M.C., Zakowski M., Sheridan C., et al. In vivo measurements of bone marrow cellularity using volume-localized proton NMR spectroscopy. Magn. Reson. Med. 19 (1991) 85-95
49. Manolagas S.C. Bone marrow, clastic, and blastic cell system: Quo vadis?. Calcif. Tissue Int. 56 Suppl. 1 (1995) S52-S53
50. Hock J.M. Stemming bone loss by suppressing apoptosis. J. Clin. Invest. 104 (1999) 371-373
51. Kuznetsov S.A., Kresbsback P.H., Satomura K., Kerr J., Riminucci M., Benayahu D., et al. Single-colony derived strains of human marrow stromal fibroblast form bone after transplantation in vivo. J. Bone Miner. Res. 12 (1997) 1335-1347
52. Watson P., Watson A., and Hodsman A. Expression of growth factor ligand and receptor genes in rat cancellous bone trabecular and marrow. J. Mol. Endocrinol. 17 (1996) 45-54
53. Lips P., Van Ginkel F.C., and Netelenbos J.C. Bone marrow and bone remodeling. Bone 6 (1985) 343-344
54. Perez-Amodio S., Beertseen W., and Everts V. (Pre-) osteoclasts induce retraction of osteoblasts before their fusion to osteoclasts. J. Bone Miner. Res. 19 (2004) 1722-1734
55. Beeton C.A., Bord S., Ireland D., and Compston J.E. Osteoclast formation and bone resorption are inhibited by megakaryocytes. Bone 39 (2006) 985-990
56. Kacena M.A., Nelson T., Clough M.E., Lee S.-K., Lorenzo J.A., Grundberg C.M., et al. Megakaryocyte-mediated inhibition of osteoclast development. Bone 39 (2006) 991-999
57. Calvi L.M., Adams G.B., Weibrecht K.W., Weber J.M., Olson D.P., Knight M.C., et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425 (2003) 841-846
58. Marshall D., Johnell O., and Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fracture. BMJ 312 (1996) 1254-1259
59. Delmas P.D., and Seeman E. Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy. Bone 34 (2004) 599-604
60. Hochberg M.C., Greenspan S., Wasnich R.D., Miller P., Thompson D.E., and Ross P.D. Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents. J. Clin. Endocrinol. Metab. 87 (2002) 1586-1592
61. Sakar S., Mitlak B.H., Wong M., Stock J.L., Black D.M., and Harper K.D. Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy. J. Bone Miner. Res. 17 (2002) 1-10
62. Riggs B.L., Wahner H.W., Dunn W.L., Mazess R.B., Offord K.P., and Melton III L.J. Differential changes in bone mineral density of the appendicular and axial skeleton with aging. J. Clin. Invest. 67 (1981) 328-335
63. Neer R.M., Arnaud C.D., Zanchetta J.R., Prince R., Gaich G.A., and Mitlak B.H. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N. Engl. J. Med. 344 (2001) 1434-1441
64. Black D.M., Greenspan S.L., Ensrud D.E., Palermo L., McGowan J.A., Lang T.F., et al. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N. Engl. J. Med. 349 (2003) 1207-1215
65. Finkelstein J.S., Hayes A., Hunzelman J.L., Wyland J.J., Lee H., and Neer R.M. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N. Engl. J. Med. 349 (2003) 1216-1226
66. Kanis J.A., Delmas P., and Burckhardt P. Guidelines for diagnosis and management of osteoporosis. Osteoporos. Int. 7 (1997) 390-406
67. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report 843 (WHO: Geneva, 1994).
68. Technical principles of X-ray absorptiometry. In: Blake G.M., Wahner H.W., and Fogelman I. (Eds). The evaluation of osteoporosis: dual energy X-ray absorptiometry and ultrasound in clinical practice. 2nd ed. vol. 47 (1999), Martin Dunitz Ltd, London 57-69 [Chap. 3]
69. Kanis J.A., Melton III L.J., Christiansen C., Johnston C.C., and Khaltaev N. The diagnosis of osteoporosis. J. Bone Miner. Res. 9 (1994) 1137-1141
70. Melton III L.J., Chrischilles E.A., Cooper C., Lane A.N., and Riggs B.L. Perspective: how many women have osteoporosis?. J. Bone Miner. Res. 7 (1992) 1005-1010
71. Lu Y., Genant H.K., Shepherd J., Zhao S., Mathur A., Fuerst T.P., et al. Classification of osteoporosis based on bone mineral densities. J. Bone Miner. Res. 16 (2001) 902-910
72. Baran D.T., Faulkner K.G., Genant H.K., Miller P.D., and Pacifici R. Diagnosis and management of osteoporosis: guidelines for utilization of bone densitometry. Calc. Tissue Int. 61 (1997) 440-443
73. Melton III L.J. How many women have osteoporosis now?. J. Bone Miner. Res. 10 (1995) 175-177
74. Reid I.R., Evans M.C., and Ames R.W. Volumetric bone density of the lumbar spine is related to fat mass but not lean mass in normal postmenopausal women. Osteoporos. Int. 4 (1994) 362-367
75. Compston J.E., Laskey M.A., Croucher P.L., Coxon A., and Kreitzman S. Effect of diet-induced weight loss on total body bone mass. Clin. Sci. (Lond) 82 (1992) 429-432
76. Harris S.S., and Dawson-Hughes B. Weight, body composition, and bone density in postmenopausal women. Calcif. Tissue Int. 59 (1996) 428-432
77. Glauber H.S., Vollmer W.M., Nevitt M.C., Ensrud K.E., and Orwoll E.S. Body weight versus body fat distribution, adiposity, and frame size as predictors of bone density. J. Clin. Endocrinol. Metab. 80 (1995) 1118-1123
78. Dawson-Hughes B., Shipp C., Sadowski L., and Dallal G. Bone density of the radius, spine, and hip in relation to percent of ideal body weight in postmenopausal women. Calcif. Tissue Int. 40 (1987) 310-414
79. Reid I.R., Ames R.W., Evans M.C., Shape S.J., Gamble G.D., France J.T., et al. Determinants of total body and regional bone mineral density in normal postmenopausal women-A key role for fat mass. J. Clin. Endocrinol. Metab. 79 (1992) 45-51
80. Reid I.R., Ames R.W., Evans M.C., Shape S.J., and Gamble G.D. Determinants of the rate of bone loss in normal postmenopausal women. J. Clin. Endocrinol. Metab. 79 (1995) 950-954
81. Reid I.R., Legge M., Stapleton J.P., Evans M.C., and Grey A.B. Regular exercise dissociates fat mass and bone density in premenopausal women. J. Clin. Endocrinol. Metab. 80 (1994) 1764-1768
82. Slemenda C.W. Body composition and skeletal density: mechanical loading or something more?. J. Clin. Endocrinol. Metab. 80 (1995) 1761-1763
83. Bevier W.C., Wiswell R.A., Pyka G., Kozak K.C., Newhall K.M., and Marcus R. Relationship of body composition, muscle strength, and aerobic capacity to bone mineral density in older men and women. J. Bone Miner. Res. 4 (1989) 421-432
84. Harris C., Dallal G.E., and Dawson-Hughes B. Influence of body weight on rates of change in bone density of the spine, hip, and radius in postmenopausal women. Calcif. Tissue Int. 50 (1992) 19-23
85. Reid I.R., Plank L.D., and Evans M.C. Fat mass is an important determinant of whole body bone density in premenopausal women but not in men. J. Clin. Endocrinol. Metab. 75 (1992) 779-782
86. Khosla S., Atkinson E.J., Riggs B.L., and Melton III L.J. Relationship between body composition and bone mass in women. J. Bone Miner. Res. 11 (1996) 857-863
87. Custer R.P. An atlas of the blood and bone marrow (1974), Saunders, Philadelphia, USA [Chap. 2]
88. Kricun M.R. Red-yellow marrow conversion: its effect on the location of some solitary bone lesions. Skelet. Radiol. 14 (1985) 10-19 [in which earlier works, circa 1930, are referenced and summarized]